HPV Vaccination Rates: Reminders & Feedback Boosts Coverage
- The human papillomavirus (HPV) is a common infection that can lead to several cancers, including cervical, anal, and head and neck cancers.
- A recent study published in JAMA Network Open on July 7, 2025, sheds light on the effectiveness of a multi-pronged approach to increase HPV vaccination rates.
- The results showed a critically importent increase in both HPV vaccine initiation and completion rates with the intervention.
Boosting HPV Vaccine Rates: A Targeted Approach with Uneven Results
Table of Contents
Published August 19, 2025
The Importance of HPV Vaccination
The human papillomavirus (HPV) is a common infection that can lead to several cancers, including cervical, anal, and head and neck cancers. Vaccination against HPV is a highly effective preventative measure, and public health officials recommend routine vaccination for adolescents. However, despite the benefits, HPV vaccination rates remain lower than desired, especially among vulnerable populations.
New Research highlights Intervention Successes and Disparities
A recent study published in JAMA Network Open on July 7, 2025, sheds light on the effectiveness of a multi-pronged approach to increase HPV vaccination rates. Researchers analyzed data from a trial involving 6,232 children aged 11-12 (52.7% boys) in Minnesota, between April 2018 and August 2022.The study compared “usual care” to an “interventional care” group, which received parent reminder letters and audit/feedback reports for healthcare professionals.
The results showed a critically importent increase in both HPV vaccine initiation and completion rates with the intervention. Initiation rates rose from 9.2% to 24.0%,and completion rates improved from 19.4% to 31.2% for most children. However, this success wasn’t worldwide. The intervention proved less effective for children belonging to the Black race, those living in rural areas, and, crucially, those residing in areas of highest socioeconomic deprivation.
Socioeconomic Disadvantage: A Persistent Barrier
The study revealed a clear correlation between socioeconomic status and HPV vaccination rates. Under usual care, vaccination initiation and completion rates steadily declined as Area Deprivation Index (ADI) quartiles increased – meaning rates were lower in more deprived areas. This trend highlights the significant impact of social determinants of health on preventative care access and uptake.The ADI is a composite measure of socioeconomic disadvantage, incorporating factors like poverty, unemployment, and education levels.
Specifically, the Cochran-Armitage test for trend showed a statistically significant decline in initiation (-0.02, P < .001) and completion (-0.05, P < .001) rates with each increasing ADI quartile.
Racial and Geographic Variations
| demographic group | Initiation rate (%) | Completion Rate (%) |
|---|---|---|
| Hispanic | 24.0 | 26.8 |
| Asian | 16.2 | 31.2 |
| White | 14.8 | 25.6 |
| Black | 2.2 | 19.4 |
While the intervention showed overall success, disparities persisted. Hispanic children had the highest initiation rates (24%), while Black children had the lowest (2.2%). Asian children demonstrated the highest completion rates (31.2%), with Black children again showing the lowest (19.4%). Gains in vaccination were similar in urban and rural settings, but were most pronounced in the least deprived areas and minimal in the most deprived.
What This Means for Practise
The study authors emphasize the need to address “place-based variations” in HPV vaccination. This means recognizing that the factors influencing vaccination rates differ depending on the community. Further research is needed to identify the specific barriers faced by patients and healthcare professionals in the most deprived areas. Potential solutions could include mobile vaccination clinics, community outreach programs, and culturally tailored educational materials.
It’s also important to acknowledge that the study had limitations. The analysis was based on data from only six primary care clinics in Minnesota, which may not be representative of the entire country. Additionally, the study period coincided with the COVID-19 pandemic, which may have influenced vaccination rates due to disruptions in healthcare access and increased vaccine hesitancy.
looking Ahead
Despite these limitations, this research provides valuable insights into the complexities of HPV vaccination. By acknowledging and addressing the disparities highlighted in this study, we can work towards ensuring that all children have access to this life-saving vaccine.Continued investment in research and targeted interventions is essential to close the gap and protect future generations from HPV-related cancers.
